Using Virtual Reality to Reduce Sedation During Endoscopy
Pilot Proof of Concept Study for Implementing Virtual Reality (VR) to Reduce Sedation Requirement During Endoscopy
NA · NYU Langone Health · NCT06349564
This study is testing if using Virtual Reality during endoscopy can help adults feel more comfortable with less sedation and recover faster.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 10 (estimated) |
| Ages | 21 Years to 65 Years |
| Sex | All |
| Sponsor | NYU Langone Health (other) |
| Locations | 1 site (Brooklyn, New York) |
| Trial ID | NCT06349564 on ClinicalTrials.gov |
What this trial studies
This study involves patients aged 21 to 65 who are undergoing screening colonoscopy or diagnostic upper endoscopy for conditions like GERD or dyspepsia. Participants will receive minimal sedation while wearing Virtual Reality (VR) goggles throughout the procedure. The aim is to evaluate the feasibility, effects, and safety of VR in reducing sedation needs, improving patient satisfaction, and shortening recovery time. The intervention utilizes a Pico 4 Enterprise headset with noise-cancelling headphones.
Who should consider this trial
Good fit: Ideal candidates are adults aged 21 to 65 undergoing screening colonoscopy or diagnostic upper endoscopy for GERD or dyspepsia.
Not a fit: Patients with visual impairments, a history of cardiovascular disease, seizures, vertigo, allergies to plastic, or active gastrointestinal bleeding may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could lead to less sedation required during endoscopic procedures, enhancing patient comfort and recovery.
How similar studies have performed: While the use of VR in medical settings is gaining interest, this specific application for reducing sedation during endoscopy is relatively novel and has not been extensively tested in prior studies.
Eligibility criteria
Show full inclusion / exclusion criteria
INTERVENTION GROUP Inclusion Criteria: * Undergoing screening colonoscopy or diagnostic upper endoscopy for GERD or dyspepsia at NYU Langone Brooklyn Hospital * Aged 21 to 65 Exclusion Criteria: * Visual impairments such as blindness which would impair them from watching the entertainment videos. * Patients with history of CAD, * History of seizures, * History of vertigo, * History of allergy to plastic, * ASAII or III, * Patient with active GI bleed, having either melena or hematochezia. CONTROL GROUP Inclusion Criteria: * Underwent screening colonoscopy or diagnostic upper endoscopy for GERD or dyspepsia at NYU Langone Brooklyn Hospital * Aged 21 to 65 Exclusion Criteria: * Visual impairments such as blindness which would impair them from watching the entertainment videos * Patients with history of CAD * History of seizures * History of vertigo * History of allergy to plastic * ASAII or III * Patient with active GI bleed, having either melena or hematochezia
Where this trial is running
Brooklyn, New York
- NYU Langone Brooklyn — Brooklyn, New York, United States (RECRUITING)
Study contacts
- Principal investigator: Maysaa El Zoghbi, MD — NYU Langone Health
- Study coordinator: Maysaa El Zoghbi, MD
- Email: Maysaa.ElZoghbi@nyulangone.org
- Phone: 216-835-7626
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Sedative During Endoscopy, GERD, Dyspepsia, screening colonoscopy, diagnostic upper endoscopy, Gastroesophageal reflux disease